CD19-POSITIVE LEUKEMIA
Clinical trials for CD19-POSITIVE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CD19-POSITIVE LEUKEMIA trials appear
Sign up with your email to follow new studies for CD19-POSITIVE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered donor cells take on childhood leukemia in first human test
Disease control Recruiting nowThis early-stage trial tests a new type of cell therapy for children and young adults up to age 21 with a form of leukemia (CD19-positive) that has returned or not responded to treatment. The therapy uses immune cells from a family donor that are engineered in a lab to recognize …
Matched conditions: CD19-POSITIVE LEUKEMIA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Engineered immune cells take on tough leukemia in kids
Disease control Recruiting nowThis study tests a personalized cell therapy for children and young adults with a type of leukemia that has come back or not responded to standard treatment. Doctors collect the patient's own immune cells, modify them to recognize and attack cancer cells, and give them back after…
Matched conditions: CD19-POSITIVE LEUKEMIA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC